Accuracy of a Novel “Factory-Calibrated” Continuous Glucose Monitoring Device in Normal Glucose Levels: A Pilot Study

@inproceedings{Murata2017AccuracyOA,
  title={Accuracy of a Novel “Factory-Calibrated” Continuous Glucose Monitoring Device in Normal Glucose Levels: A Pilot Study},
  author={Takashi Murata and Shinsuke Nirengi and Yaeko Kawaguchi and Shin Sukino and Tomokazu Watanabe and Naoki Sakane},
  year={2017}
}
Free Style Libre Pro, a novel continuous glucose monitoring (CGM) device for retrospective assessment of glycemic excursion, does not require calibration during the measurement period. In this study, the accuracy of FreeStyle Libre Pro in normal glucose levels was investigated. Two meal tests, on the 7th day and 9th day of CGM usage, were performed in five non-diabetic adults. Venous blood samples were obtained at baseline, and at 2 hours, 4 hours and 6 hours after the meal. The plasma glucose… 

Tables from this paper

Assessment of the accuracy of an intermittent‐scanning continuous glucose monitoring device in patients with type 2 diabetes mellitus undergoing hemodialysis (AIDT2H) study

  • M. ToyodaT. Murata K. Hosoda
  • Medicine
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
  • 2021
The accuracy of FreeStyle Libre in patients undergoing HD became deteriorated with the days of usage, and its insufficient accuracy necessitates adjunct usage of Free Style Libre with self-monitoring of blood glucose (SMBG) in patients facing hemodialysis.

Using Digital Health Technologies to Understand the Association Between Movement Behaviors and Interstitial Glucose: Exploratory Analysis

Evidence of an acute stimulus-response model was observed between sedentary time, physical activity, and glucose variability in low fitness individuals, with sedentaryTime and light activity conferring the most consistent changes in glucose variability.

Toward Long-Term Implantable Glucose Biosensors for Clinical Use

A fully implantable sensor with a longer-term lifespan (90 days) is considered as an alternative CGM sensor with high comfort and low running cost, but it still has barriers, including surgery for applying and replacing and frequent calibration.

References

SHOWING 1-10 OF 22 REFERENCES

A Multicenter Evaluation of the Performance and Usability of a Novel Glucose Monitoring System in Chinese Adults With Diabetes

The flash glucose monitoring system works well for people with diabetes in China, and it is easy to wear and use.

Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system ((Biostator).

The Glucose-Controlled Insulin Infusion System (Biostator) is a modular, computerized, feedback control system for dynamic control of blood glucose concentrations in diabetics that utilizes a novel enzyme (glucose oxidase)-membrane configuration and an electrochemical cell to measure the H202 generated.

A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 Diabetes

FreeStyle Libre had a similar overall MARD as continuous blood glucose monitoring systems in earlier studies when studied in similar at-home conditions and patients' experience with the system was generally positive.

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

Interstitial glucose measurements with the FreeStyle Libre system were found to be accurate compared with capillary BG reference values, with accuracy remaining stable over 14 days of wear and unaffected by patient characteristics.

Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor

The Guardian Sensor 3 glucose sensor, whether located in abdomen or the arm, provided accurate glucose readings when compared with the YSI reference and demonstrated functional life commensurate with the intended 7-day use.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Benefit of CGM for patients starting on CGM sensor augmented insulin pump therapy compared to patients using multiple daily injections of insulin (MDI) and standard monitoring blood glucose (SMBG) is indicated.

Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.

  • D. Rodbard
  • Medicine
    Diabetes technology & therapeutics
  • 2016
Continuous glucose monitoring in conjunction with an insulin pump with automated suspension of insulin infusion in response to actual observed or predicted hypoglycemia, as well as progressive refinement of closed-loop systems, is expected to dramatically enhance the clinical utility and utilization of CGM.

Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology

The main advantages of factory calibration over the conventional user calibration are: more convenience for the user, since no more fingersticks are required for calibration and elimination of use errors related to the execution of the calibration process, which can lead to sensor inaccuracies.

Time Lag of Glucose From Intravascular to Interstitial Compartment in Type 1 Diabetes

In the overnight fasted state in T1D adults, the delay of glucose appearance from the vascular to the interstitial space is less than 10 minutes, thereby implying that this minimal physiological time lag should not be a major impediment to the development of an effective closed-loop control system for type 1 diabetes.

A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose.

The consensus EGs furnish a new tool for evaluating errors in the measurement of BG for patients with type 1 and type 2 diabetes, and differ from the traditional EG in several significant ways.